Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01041976 · ClinicalTrials.gov registry record · Phase 2
Supported Employment: Motivational Enhancement for Entry and Outcome
A Phase 2 study of Bipolar Disorder and Psychotic Disorders, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT01041976 is a Phase 2 study of Bipolar Disorder and Psychotic Disorders that has completed, run by VA Office of Research and Development. The registered enrollment target is 168 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01041976, a Phase 2 study of Bipolar Disorder and Psychotic Disorders, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare 6 monthly counseling sessions to 6 monthly information sessions on Veterans' decisions to (a) participate in vocational rehabilitation services and (b) become employed.
Conditions Studied
Interventions
- BEHAVIORAL Adapted Motivational Interviewing (AMI)
- BEHAVIORAL Support and Education for Recovery (SER)
Study Locations (1)
Massachusetts
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01041976
The ClinicalTrials.gov registry entry for NCT01041976 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (49% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Adapted Motivational Interviewing (AMI) is the first listed.
NCT01041976 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01041976 about?
NCT01041976 is a clinical study titled "Supported Employment: Motivational Enhancement for Entry and Outcome". The purpose of this study is to compare 6 monthly counseling sessions to 6 monthly information sessions on Veterans' decisions to (a) participate in vocational rehabilitation services and (b) become employed.
What is the current status of trial NCT01041976?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2011-01. Estimated completion is 2015-09.
What conditions does trial NCT01041976 study?
This clinical trial studies the following conditions: Bipolar Disorder, Psychotic Disorders, Unemployment.
What interventions are being tested in trial NCT01041976?
The interventions under investigation include: Adapted Motivational Interviewing (AMI) (BEHAVIORAL), Support and Education for Recovery (SER) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01041976?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01041976 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
RECRUITING · Phase 2
-
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
RECRUITING · Phase 2
-
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
RECRUITING · Phase 2
-
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.